NCT05020184

Effect of Oral Cimetidine in the Protoporphyrias

CompletedPHASE2INTERVENTIONAL

Trial Details

Start: 2022-06-14Est. Completion: 2025-04-24

Enrollment target: 26 participants

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
University of Texas Medical Branch, Galveston, Texas, United States

Erythropoietic Protoporphyria

This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in pa…

Birmingham, United StatesCompleted Jun 2028

EPPXLP

To evaluate the long-term safety and tolerability of oral dersimelagon.

Huntington Beach, United StatesEst. completion Dec 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.